Companies: 10,795·Total market cap: $144.5T

CorMedix Inc.

CorMedix Inc.

CRMDNASDAQHealthcare● Active

$8.45

+$0.09(+1.06%)

Market Cap$662816491

P/E Ratio—

52W High$17.43

52W Low$6.13

Avg Volume1.3M

Open$8.45

Beta1.47

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

CorMedix Inc.（CRMD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CRMD · 截至 Jun 8, 2026

关键指标

EPS (TTM)$2.38Earnings history

PE Ratio (TTM)3.5×PE Ratio deep dive

Revenue (TTM)$400.1MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding72.0MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 CorMedix Inc. 数据

分析师预测$14 · Buy

股息不分红

营收$311.7M+617.03%

盈利EPS $2.25+850.00%

财务快照

FY 2025Revenue$311.7M▲ +617.03% YoY

202320242025

FY 2025Net Income$163.1M▲ +1009.40% YoY

202320242025

FY 2025EPS$2.25▲ +850.00% YoY

202320242025

TTM:Revenue: $400.1MNet Income: $181.0MEPS: $2.38View income statement →

分析师评级与目标价

Buy8 位分析师

Strong Buy

0

Buy

8

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$13.00Low

$8.45Current

$14.00Avg Target上涨空间 65.71%

$16.00High

合计: 8 · 买入占比: 100.0%

根据过去 3 个月内 8 位华尔街分析师，CRMD 共识评级为 Buy，12 个月平均目标价 $14.00 （较现价 $8.45 上涨空间 65.71%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$8.45+1.06%$662.8M #2

Arbutus Biopharma Corporation

$4.22-0.59%$833.6M #3

Bicara Therapeutics Inc. Common Stock

$19.95-0.22%$1.1B #4

EyePoint Pharmaceuticals, Inc.

$11.49-2.42%$963.3M #5

Kura Oncology, Inc.

$8.57-2.63%$760.8M #6

Nanobiotix S.A.

$35.66-1.21%$1.8B

股票表现

1D+0.96%

1W+3.05%

1M+6.57%

3M+30.65%

YTD-27.43%

1Y-41.18%

5Y+5.24%

关于 CorMedix Inc.

CEOJoseph Todisco

IPO DateMay 13, 2010

Employees64

CountryUS

Websitecormedix.com

CorMedix Inc. a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

CorMedix Inc.（CRMD）是 Biotechnology 行业的 Healthcare 类公司，于 May 13, 2010 在 NASDAQ 上市。截至最近交易日，CRMD 股价为 $8.45，市值约为 $662.1M。过去12个月累计回报 -41.18%，年初至今回报 -27.43%。

根据 8 位华尔街分析师，CorMedix Inc. 股票共识评级为Buy，12个月平均目标价为 $14.00。2025 财年 CorMedix Inc. 营收 $311.7M，净利润 $163.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，CorMedix Inc.（CRMD）股价为 $8.45，在 NASDAQ 上市，52周区间为 $6.13 – $17.43。

CRMD 最新股价CRMD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议